| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | AGEs|advanced glycation end products |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
human AGE (Advanced glycation end-product) is a molecular target commonly studied in biomedical research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of AGE is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of AGE can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
AGE (Advanced glycation end-product) may also be referenced as AGEs and advanced glycation end products in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how AGE relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.
- Interpreting shifts in AGE levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
AGE has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Activating the Osteoblastic USP26 Pathway Alleviates Multi‐Organ Fibrosis by Decreasing Insulin Resistance
IF: 14.1 Journal: Advanced Science Author: Department of Orthopedics, Shanghai Institute of Traumatology and Orthopedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Cited Date: 2025-12-26
Semaglutide Enhances Cellular Regeneration in Skin and Retinal Cells In Vitro
IF: 5.5 Journal: Pharmaceutics Author: Department of Propaedeutic Internal Medicine, 'Laiko' General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece. Cited Date: 2025-10-17
Comparison of bovine serum albumin glycation by ribose and fructose in vitro and in vivo
IF: 5.187 Journal: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease Cited Date: 2021-10-09
Defective Intracellular Insulin/IGF-1 Signaling Elucidates the Link Between Metabolic Defect and Autoimmunity in Vitiligo
IF: 5.1 Journal: Cells Author: Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy Cited Date: 2025-04-18
Markers of Metabolic Abnormalities in Vitiligo Patients
IF: 4.9 Journal: International Journal of Molecular Sciences Author: Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy Cited Date: 2024-09-27
Effect of ribose-glycated BSA on histone demethylation
IF: 4.772 Journal: Frontiers in Genetics Author: School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China Cited Date: 2023-05-12
Advanced Glycation End-Products of Follicular Fluid are Associated with Embryo Morphokinetic Parameters and ART Outcomes
IF: 2.9 Journal: Reproductive Sciences Author: Pooyesh Fertility Center, Isfahan, Iran. Cited Date: 2024-04-26
Chronic Bisphenol-A Exposure Enhances ROS and AGEs Production via the RAGE/PI3K/AKT/mTOR Signaling Pathway, Inducing Apoptosis in Human Pancreatic β-Cells
IF: 2.8 Journal: Journal of Biochemical and Molecular Toxicology Author: Diabetes Center, First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece. Cited Date: 2025-11-14
Genetic Variation in the Receptor for Advanced Glycation End Product (1704G?>?T) and Matrix Metalloproteinase-9 (-1562 C/T) in Type 2 Diabetic Patients with Nephropathy in Western Rajasthan
IF: 1.6 Journal: Indian Journal of Clinical Biochemistry Author: Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, Jodhpur, India Cited Date: 2025-08-22
First trimester screening of serum advanced glycation end products levels of pregnant women who have risk factors for gestational diabetes and their obstetric outcomes: a preliminary case-control study
IF: 1.246 Journal: Journal of Obstetrics and Gynaecology Cited Date: 2022-06-09